Henry Schein Announces Further Efforts to Address the COVID-19 Pandemic
The company announced today that it will serve as the exclusive distributor in the United States of a second point-of-care rapid test kit that can detect antibodies associated with COVID-19 in as few as 15 minutes.
Synchrocyclotron for the MEVION S250i Proton Therapy System Delivered to Huntsman Cancer Institute
The proton center at Huntsman Cancer Institute at the University of Utah will be the first in the Mountain West to use the MEVION S250i Proton Therapy System.
Sectra Digital Pathology Module Receives FDA Clearance
The clearance applies for Sectra Digital Pathology Module, the key component of Sectra's pathology solution, when used together with Leica Biosystems' scanner AT2 DX. This enables US healthcare providers to use Sectra's digital pathology solution for primary diagnostics. The solution makes it possible to move towards fully integrated diagnostics, which is especially important in complex cancer cases.
COVID Care’s COVID-19 IgG and IgM Rapid Test Now Authorized Pursuant to FDA EUA Guidance
The Covid Care Rapid Test has a 91% Clinical Sensitivity rating, and a 99% Clinical Specifity rating.
Datos Health COVID-19 Solution Employed at Rochester Regional Health
The partnership is enabling Rochester Regional Health to more efficiently and safely monitor patients and healthcare workers exposed to or suffering from coronavirus, outside of the hospital setting notes Datos Health.